Becker's Healthcare July 13, 2018
Pharmaceutical and biotech companies have the biggest effect on healthcare costs, most healthcare providers told an NEJM Catalyst Buzz survey.
The survey, sponsored by Salt Lake City-based University of Utah Health, was conducted by NEJM Catalyst in April among 571 NEJM Catalyst Insights Council members. Council members include U.S. executives, clinical leaders and clinicians at healthcare delivery organizations.
Four survey findings:
1..Sixty-two percent said out-of-pocket expenses are “extremely important” to patients, while 32 percent said they are “very important” to patients.
2. Clinical decisions are informed by healthcare costs. Seventy-six percent of respondents said the cost to practice/system is considered in clinical decisions at their organization. Seventy-two percent said out-of-pocket cost for the patient is considered in clinical decision-making, and...